ASTRAZEN
Astrazeneca Pharma India Ltd.
Pharmaceuticals & Drugs
Setup readiness
Late Stage
- Pivot Levels
- ₹8766.9-9195.8
- Support Level
- ₹8797.7
- Resistance
- ₹10980.0
- Risk Distance
- 4.3% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Mixed technical setup
Stage 4 trend context — relative strength and breakout quality remain primary constraints.
Bullish factors
- MACD below zero — weak trend (−2).
- Price remains below the 50DMA (intermediate trend reference).
- Reasonable 52w-high proximity (-15% below).
- Relative strength remains low versus the broader market.
- Trend stage reads as Stage 4.
- 1 prior pivot rejection in last 60d (-8 pts).
- ATR shrinking 3 consecutive weeks — coil forming.
- BB squeeze — energy building.
- RSI 46 — ideal setup zone.
- Handle formation detected after prior advance.
- Volume flow indicates accumulation.
Risk factors
- 5 distribution days observed recently
- High failure risk score (66/100)
- Stage reads as Stage 4 (not Stage 2)
Overall view
The setup is still developing with mixed momentum and trend alignment.
Setup research
ASTRAZEN — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Positives
Price is 8% below the pivot
- Volume contracting into the base
- Handle formation detected after prior advance
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 4 — caution
- Sector Mid-pack (#23/46)
- Relative strength Lagging (RS 42)
- Trend strength Weak (ADX 11)
Negatives
This idea is wrong below ₹8797.7 (-4.8% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹8797.7
- Pivot — failure re-entry below₹9150.0
Risk distance
Risk ≈ ₹398.07/share from entry ₹9195.8.
Reasons to skip 3
Disqualifiers that apply even if the score looks good.
- 5 distribution days observed recently
- High failure risk score (66/100)
- Stage reads as Stage 4 (not Stage 2)
Setup metrics Latest scan
ASTRAZEN Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest research scan.
Volume Profile neutral
- POC
- ₹8439.56
- VAH
- ₹8810.92
- VAL
- ₹8229.65
- Vol above POC
- 54.2%
Institutional Activity · Moderate Accumulation
- Avg cost basis
- ₹8711.85
- Acc zone
- ₹8024.0–8895.0
- Accumulation sessions
- 2
- CMF
- 0.08
Structure
Momentum
Risk
More scanner fields
ASTRAZEN Support & Resistance Levels
Research chart
Daily price action with pivot, support, and resistance levels from our latest scan, plus relative strength vs Nifty.
Pivot levels, support and resistance are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Seasonality — monthly returns
How this stock moved month by month over the last ~2 years.
A rough tendency, not a reliable pattern. Research only, not advice.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Pattern highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
ASTRAZEN FAQ Common swing-trading questions
Frequently asked questions about ASTRAZEN
What are the screener observations for ASTRAZEN?
On Swing Edge's swing-setup framework, Astrazeneca Pharma India Ltd. (ASTRAZEN) currently grades D — low-quality — likely skip. Price is 8% below the pivot. Flagged yesterday. This is educational research, not investment advice.
What are ASTRAZEN's support and resistance levels?
For ASTRAZEN, near-term support sits around ₹8,797.7 (the base/stop zone); overhead resistance is around ₹9,150.0 (the breakout pivot); the next resistance above is ₹10,980.0. This is educational research, not investment advice.
What is the breakout / pivot level for ASTRAZEN?
The breakout pivot for ASTRAZEN is around ₹9,150.0. Price is about 8.3% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is ASTRAZEN above its 50-day and 200-day moving averages?
ASTRAZEN is currently in Stage 4, not a confirmed Stage 2 uptrend, so trend support from the key moving averages is weaker than ideal for a swing entry. This is educational research, not investment advice.
How strong is ASTRAZEN versus the market (RS rank)?
ASTRAZEN has a relative strength (RS) rank of 42 out of 100 versus the NSE universe, making it lagging the broader market on relative strength. Trend strength (ADX) reads 11, indicating a weak/choppy trend. This is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-28 — not live intraday NSE quotes.